Johnson & Johnson
JNJ
$146.82
-$1.71-1.15%
| 12/31/2023 | 10/01/2023 | 07/02/2023 | 04/02/2023 | 01/01/2023 | |
|---|---|---|---|---|---|
| Revenue | 85.16B | 83.70B | 82.35B | 81.31B | 79.99B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 85.16B | 83.70B | 82.35B | 81.31B | 79.99B |
| Cost of Revenue | 26.24B | 25.61B | 25.41B | 25.19B | 24.60B |
| Gross Profit | 58.92B | 58.09B | 56.94B | 56.12B | 55.39B |
| SG&A Expenses | 20.17B | 19.74B | 19.33B | 19.23B | 19.08B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 61.50B | 59.67B | 59.09B | 58.66B | 57.81B |
| Operating Income | 23.66B | 24.03B | 23.26B | 22.65B | 22.18B |
| Income Before Tax | 15.06B | 14.08B | 14.03B | 12.76B | 19.36B |
| Income Tax Expenses | 1.74B | 1.66B | 1.61B | 1.61B | 2.99B |
| Earnings from Continuing Operations | 13.33K | 12.42K | 12.42K | 11.15K | 16.37K |
| Earnings from Discontinued Operations | 21.64B | 22.01B | 441.00M | 441.00M | 441.00M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 35.15B | 34.62B | 13.05B | 12.72B | 17.94B |
| EBIT | 23.66B | 24.03B | 23.26B | 22.65B | 22.18B |
| EBITDA | 30.77B | 30.81B | 29.89B | 29.09B | 28.51B |
| EPS Basic | 13.73 | 13.62 | 5.00 | 4.85 | 6.83 |
| Normalized Basic EPS | 6.10 | 6.48 | 6.21 | 5.84 | 5.68 |
| EPS Diluted | 13.60 | 13.46 | 4.92 | 4.77 | 6.73 |
| Normalized Diluted EPS | 6.04 | 6.40 | 6.13 | 5.78 | 5.60 |
| Average Basic Shares Outstanding | 10.50B | 10.36B | 10.46B | 10.49B | 10.51B |
| Average Diluted Shares Outstanding | 10.55B | 10.45B | 10.56B | 10.60B | 10.66B |
| Dividend Per Share | 4.70 | 4.64 | 4.58 | 4.52 | 4.45 |
| Payout Ratio | 25.32% | 25.96% | 91.60% | 93.03% | 65.11% |
